Blackman A

Canadian Centre for Psychedelic Science, Toronto, Ontario, Canada.

2 papers · 2 preprints

ArticlePsilocybin

Microdosing psilocybin for major depressive disorder: study protocol for a phase II double-blind placebo-controlled randomised partial crossover trial - CORRIGENDUM.

Beidas Z, Ragnhildstveit A, Blackman A +8

Europe PMC2026
PreprintPsilocybin

Safety and Efficacy of Microdosing Psilocybin over 8 Weeks for Major Depressive Disorder: A Randomized Clinical Trial

Petranker R, Farb N, Syed O +4

Europe PMC2026
ArticlePsilocybin

Microdosing psilocybin for major depressive disorder: study protocol for a phase II double-blind placebo-controlled randomised partial crossover trial.

Beidas Z, Ragnhildstveit A, Blackman A +9

Europe PMC2026
PreprintPsilocybin

Microdosing Psilocybin for Major Depressive Disorder: Study Protocol for a Phase II Double-Blind Placebo-Controlled Randomized Partial Crossover Trial

Beidas Z, Ragnhildstveit A, Blackman A +9

Europe PMC2025